Excellentia Advisory Group through sponsorship with Knowledge Network is giving back to our valued clients. Excellentia is proud to present one in a series of monthly complimentary educational webinars presented by vendors in the field of Infection Prevention for the ambulatory surgery center industry.
January 2012 webinar:
“Biofilms in Medicine: Implications for Ambulatory Surgical Centers”
Presented by: Wava Truscott, PhD
January 17, 2012
Wava Truscott, PhD., is Director of Medical Sciences & Clinical Education for Kimberly-Clark Health Care. Her doctorate is in Comparative Pathology emphasizing Microbiology, Immunology, and Pathology from the University of California. Her MBA is from the University of La Verne and her BS from Brigham Young University (BYU). Earlier in her career, Wava evaluated the safety and efficacy of medical devices at MIDECO Independent Laboratories, Managed the Biological Laboratories for the Pharmaseal Division of Baxter Healthcare, and was Vice President of Scientific Affairs for the SafeSkin Corporation. She spent years researching latex allergy from profiling the allergens derived from tapping the plantation trees, processing the latex and producing the gloves to developing ways to remove the offending proteins.
Dr. Truscott has authored over 70 articles, co-authored the Microbiological section of the AAMI Sterilization Recommended Practices, and served as the U.S. delegate to the International Standards Organization on Biocompatibility Testing of Medical Devices regarding Systemic Toxicity (ISO 10993-11) as the European Union was forming. She recently authored an extensive petition to the FDA requesting a ban on all powdered gloves used in healthcare and is currently the ASTM Chairman of the committee charged with developing test methods for medical gloves incorporated with antimicrobial agents.
About This Webinar:
A biofilm is a threat to optimal patient recovery. It is a collection of bacteria that attach tenaciously to an organic or inorganic surface and rapidly form a slimy/glue-like protective coating that shields this highly organized community of pathogens from assault soaps, disinfectants, antibiotics, the human immune defenses and even sterilization. Yet, these encased microorganisms are capable of launching either aggressive or insidious infections with remarkable stealth. This course will discuss the role of microbial biofilms in human infections generally, describe their formation sequence, explain how biofilms on poorly cleaned instruments and in the healthcare environment cause poor and often serious, patient outcomes while explaining these risks can be reduced. Patient consequences include loss of visual acuity, blood stream infections, breast implant contractures, device implant infections, severe Clostridium difficile outbreaks, tuberculosis, hepatitis, endocarditis, joint degradation, loss of muscle mass, significant disfigurement and even death.
1. Identify biofilm characteristics that render them threats to optimal patient outcomes
2. Describe patient consequences of biofilm infections
3. List how we can reduce the threat of biofilms for patients undergoing surgery
You will receive one-hour of continuing education credit* for attending this webinar. Excellentia Advisory Group will forward a Certificate of Participation for each licensed person that attends this webinar. You simply email the names and license numbers of each person to firstname.lastname@example.org.
Special Note: This webinar will be offered to the first 200 registrations so please act now to get your seat. All registrants will be sent an email after the webinar with a link for future complimentary viewings of this presentation.
*To learn more about Kimberly-Clark Infection Prevention products, go to http://www.kimberly-clark.com/brands/kc_professional.aspx
*Excellentia Advisory Group is approved by the California Board of Registered Nursing.
• Provider CEP 15481
• Issue Date: 4/6/2010
Other Archived Webinar Links
December 2011- “What Do You Mean I Caused That Surgical Complication?” Presented by: Wava Truscott, PhD, Kimberly-Clark Healthcare
January 2012 -"Biofilms in Medicine:Implications for Ambulatory Surgical Centers" Presented by: Wava Truscott, PhD, Kimberly-Clark Healthcare
February 2012 - "The New Clostridium difficile: Pathogenicty, Complications, Prevention" Presented by: Wava Truscott, PhD, Kimberly-Clark Healthcare
March 2012 -"Check the Label: Is the Mask a Level 1, 2, or 3 (and...what's the difference?)" Presented by: Kathleen Stoessel, RN, BSN, MS, Kimberly-Clark Healthcare
April 2012 - Partial- "What Every Ambulatory Surgery Center Professional Should Know About Steam Sterilization Monitoring" Presented by: Dorothy Larson, 3M Infection Prevention Division
June 2012 - "Patient Complications Caused by Sterile Lint and Powder" Presented by: Wava Truscott, PhD, Kimberly-Clark Healthcare